4-(P-TOLUENESULFONYLAMINO)PHENYLBORONIC ACID PINACOL ESTER, 97%
Product Information
Molecular Formula
C19H24BNO4S
Description
4-(p-Toluenesulfonylamino)phenylboronic acid pinacol ester, 97% is a highly purified compound predominantly used in biomedicine. Its exceptional chemical properties make it an effective tool in the development of drugs for treating various diseases, including cancer and inflammation.
Synonyms
4-(p-Toluenesulfonylamino)phenylboronic acid pinacol ester, N-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-p-toluenesulfonamide
IUPAC Name
4-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC=C(C=C2)NS(=O)(=O)C3=CC=C(C=C3)C
InChI
InChI=1S/C19H24BNO4S/c1-14-6-12-17(13-7-14)26(22,23)21-16-10-8-15(9-11-16)20-24-18(2,3)19(4,5)25-20/h6-13,21H,1-5H3
InChI Key
RLVWYHYMSBRBKK-UHFFFAOYSA-N
Flash Point
Not applicable
Purity
97%
Safety Information
Hazards
H413
Computed Properties
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
4
Exact Mass
373.1519096 g/mol
Monoisotopic Mass
373.1519096 g/mol
Topological Polar Surface Area
73Ų
Heavy Atom Count
26
Formal Charge
0
Complexity
569
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| AU-2013312477-A1 | Compounds and methods for kinase modulation, and indications therefor | 2012-09-06 |
| AU-2013312477-B2 | Compounds and methods for kinase modulation, and indications therefor | 2012-09-06 |
| EP-2892534-A2 | Compounds and methods for kinase modulation, and indications therefor | 2012-09-06 |
| JP-2015529224-A | Compounds and methods for modulating kinases and indicators thereof | 2012-09-06 |
| JP-6318156-B2 | Compounds and methods for modulating kinases and indicators thereof | 2012-09-06 |
| US-10227357-B2 | Compounds and methods for kinase modulation, and indications therefor | 2012-09-06 |
| US-2014128390-A1 | Compounds and methods for kinase modulation, and indications therefor | 2012-09-06 |
| WO-2014039714-A2 | Compounds and methods for kinase modulation, and indications therefor | 2012-09-06 |
| EP-2892534-B1 | Compounds and methods for kinase modulation, and indications therefor | 2012-09-06 |
| EP-2654752-A1 | Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans | 2010-12-22 |
